Trial Profile
Safety, tolerability and pharmacokinetics of SMP-114 (a novel candidate DMARD) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2009
Price :
$35
*
At a glance
- Drugs Rimacalib (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Acronyms ARREST
- 20 Sep 2009 New trial record.